Atrial fibrillation: Stroke prevention in focus

被引:15
|
作者
Ferguson, Caleb [1 ]
Inglis, Sally C. [1 ]
Newton, Phillip J. [1 ]
Middleton, Sandy [2 ,3 ]
Macdonald, Peter S. [3 ,4 ]
Davidson, Patricia M. [1 ,3 ]
机构
[1] Univ Technol Sydney, Fac Hlth, Ctr Cardiovasc & Chron Care, Sydney, NSW 2007, Australia
[2] Australian Catholic Univ, Natl Ctr Clin Outcomes Res NaCCOR, Sydney, NSW, Australia
[3] St Vincents Hosp, Sydney, NSW 2010, Australia
[4] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia
关键词
Atrial fibrillation; Stroke prevention; Clinical management; Anticoagulation; Thromboprophylaxis; Cardiovascular; RISK STRATIFICATION; PREDICTING STROKE; ANTITHROMBOTIC THERAPY; CATHETER ABLATION; HEART-FAILURE; TASK-FORCE; MANAGEMENT; WARFARIN; ANTICOAGULATION; PREVALENCE;
D O I
10.1016/j.aucc.2013.08.002
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Atrial fibrillation (AF) is a common arrhythmia and a risk factor for stroke and other, adverse events. Internationally there have been recent advancements in the therapies available for, stroke prevention in AF. Nurses will care for individuals with AF across a variety of primary and acute, care settings and should be familiar with evidence based therapies. Aim: This paper provides a review of the epidemiology of AF and stroke, stroke and bleeding risk, assessment tools and evidence based treatments for the prevention of stroke in AF including the use of, novel anti-thrombin agents. Method: A review of key databases was conducted from 2002 to 2012 using the key search terms 'atrial, fibrillation' anticoagulation' 'riskassessment' and 'clinical management'. The following electronic, databases were searched: CINAHL, Medline, Scopus, the Cochrane Library and Google Scholar., Reference lists were manually hand searched. Key clinical guidelines from National Institute for, Clinical Excellence (NICE, UK), American Heart Association (AHA, USA), American College of Cardiology, (ACC, USA) and the European Society of Cardiology (ESC) and key government policy documents were, also included. Articles were included in the review if they addressed nursing management with a focus, on Australia. Results: Many treatment options exist for AF. Best practice guidelines make a variety of, recommendations which include cardioversion, ablation, pulmonary vein isolation, pharmacological, agents for rate or rhythm control approaches, and antithrombotic therapy (including anticoagulation, and antiplatelet therapy). Treatment should be patient centred and individualised based upon, persistency of the rhythm, causal nature, risk and co-morbid conditions. Conclusion: AF is a common and burdensome condition where treatment is complex and not without, risk. Nurses will encounter individuals with AF across a variety of primary and acute care areas, understanding the risk of AF and appropriate therapies is important across all care settings. Treatment, must be individually tailored to the needs of the patient and balanced with the best available evidence. (C) 2013 Australian College of Critical Care Nurses Ltd. Published by Elsevier Australia (a division of Reed International Books Australia Pty Ltd). All rights reserved.
引用
收藏
页码:92 / 98
页数:7
相关论文
共 50 条
  • [1] Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients
    Li, Yan-Guang
    Lee, So-Ryoung
    Choi, Eue-Keun
    Lip, Gregory Y. H.
    KOREAN CIRCULATION JOURNAL, 2018, 48 (08) : 665 - 684
  • [2] Stroke Prevention in Atrial Fibrillation: Focus on Latin America
    Massaro, Ayrton R.
    Lip, Gregory Y. H.
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2016, 107 (06) : 576 - 588
  • [3] New advances in the treatment of atrial fibrillation: focus on stroke prevention
    Lau, Yee C.
    Lip, Gregory Y. H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (15) : 2193 - 2204
  • [4] Novel Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: Focus on Apixaban
    Tatjana S. Potpara
    Marija M. Polovina
    Marina M. Licina
    Radan M. Stojanovic
    Milica S. Prostran
    Gregory Y. H. Lip
    Advances in Therapy, 2012, 29 : 491 - 507
  • [5] Stroke Prevention in Patients With Atrial Fibrillation: Focus on New Oral Anticoagulants
    Toth, Peter P.
    POSTGRADUATE MEDICINE, 2013, 125 (03) : 155 - 161
  • [6] Novel Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: Focus on Apixaban
    Potpara, Tatjana S.
    Polovina, Marija M.
    Licina, Marina M.
    Stojanovic, Radan M.
    Prostran, Milica S.
    Lip, Gregory Y. H.
    ADVANCES IN THERAPY, 2012, 29 (06) : 491 - 507
  • [7] Atrial fibrillation and stroke prevention
    Hart, RG
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (11): : 1015 - 1016
  • [8] Atrial fibrillation: stroke prevention
    Chao, Tze-Fan
    Potpara, Tatjana S.
    Lip, Gregory Y. H.
    LANCET REGIONAL HEALTH-EUROPE, 2024, 37
  • [9] Prevention of stroke in atrial fibrillation
    Masjuan, J.
    NEUROLOGIA, 2012, 27 : 1 - 3
  • [10] Stroke prevention in atrial fibrillation
    Wagenaar, P.
    CARDIOVASCULAR JOURNAL OF AFRICA, 2011, 22 (02) : 105 - 105